VRDN short interest
Viridian Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 17,965,668 |
|---|---|
| Change vs prior report | -1,499,583 (-7.7%) |
| Change over six months | +65.7% |
| Days to cover | 8.87 (sector: 3.78) |
| Average daily volume | 2,026,431 |
| Rank in Healthcare | #156 of 922 by days to cover |
VRDN short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 17,965,668 | -7.7% | 8.87 | 2,026,431 |
| 2026-09-15 | 19,465,251 | -0.2% | 15.74 | 1,236,537 |
| 2026-08-31 | 19,511,841 | +2.5% | 16.55 | 1,178,851 |
| 2026-08-14 | 19,026,492 | -1.1% | 9.05 | 2,101,454 |
| 2026-07-31 | 19,234,874 | +1.6% | 11.31 | 1,700,002 |
| 2026-07-15 | 18,923,758 | +9.1% | 9.87 | 1,917,463 |
| 2026-06-30 | 17,342,672 | +15.5% | 5.56 | 3,118,833 |
| 2026-06-15 | 15,020,329 | +2.9% | 10.09 | 1,489,122 |
| 2026-05-29 | 14,597,487 | +2.3% | 7.89 | 1,849,463 |
| 2026-05-15 | 14,266,320 | +23.9% | 3.06 | 4,665,057 |
| 2026-04-30 | 11,512,229 | +8.0% | 6.90 | 1,667,694 |
| 2026-04-15 | 10,655,439 | -1.7% | 2.59 | 4,109,372 |
| 2026-03-31 | 10,843,213 | +31.7% | 3.96 | 2,738,346 |
| 2026-03-13 | 8,233,141 | +5.3% | 7.27 | 1,132,865 |
| 2026-02-27 | 7,819,966 | +0.8% | 5.96 | 1,312,904 |
| 2026-02-13 | 7,761,846 | -2.2% | 5.55 | 1,399,403 |
| 2026-01-30 | 7,937,926 | -2.6% | 5.38 | 1,476,001 |
| 2026-01-15 | 8,148,951 | -6.1% | 5.20 | 1,568,474 |
| 2025-12-31 | 8,681,872 | -4.0% | 6.04 | 1,437,586 |
| 2025-12-15 | 9,040,297 | -1.5% | 6.49 | 1,393,283 |
| 2025-11-28 | 9,174,113 | -3.1% | 5.03 | 1,822,466 |
| 2025-11-14 | 9,472,517 | -3.0% | 4.60 | 2,057,401 |
| 2025-10-31 | 9,762,681 | -2.2% | 5.35 | 1,825,219 |
| 2025-10-15 | 9,986,922 | -2.4% | 11.76 | 849,532 |
| 2025-09-30 | 10,235,828 | -7.0% | 15.95 | 641,896 |
import finzdata as yf
yf.Ticker("VRDN").short_interest # every report since 2017
yf.Client().short_interest(["VRDN"], start="2018-01-01")Healthcare short interest · VRDN price history · Who owns VRDN · All short interest